mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-10 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-10 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-08 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-07 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-07 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |